Christopher P. Shelburne

Author

Virginia Commonwealth University

Also Known As

C P Shelburne, C Shelburne, C. P. Shelburne, Christopher P Shelburne, Christopher P. Shelburne, Christopher Shelburne

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Virginia Commonwealth University Duke Medical Center Duke University Hospital Duke University National Institute of Allergy and Infectious Diseases

About

Christopher P. Shelburne is an author at Virginia Commonwealth University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.3K
2	Cell Biology	9	9	656
3	Allergy	7	7	655
4	Natural Sciences	1	1	12
5	Allergy Medicine	1	1	60

Christopher P. Shelburne

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Mast cell–derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection James B. McLachlan, Justin P. Hart, Salvatore V. Pizzo, Nature Immunology InflammationImmune Cell DevelopmentMast Cell DisorderPathogenesisImmunology	2003	313
Mast cell activators: a new class of highly effective vaccine adjuvants James B. McLachlan, Christopher P. Shelburne, Justin P. Hart, Nature Medicine VaccinationVaccinologyVaccine DevelopmentAllergyMedicine	2008	207
Stat5 expression is critical for mast cell development and survival Christopher P. Shelburne, Margaret E. McCoy, Roland P. Piekorz, Blood Lymphocyte DevelopmentMast Cell DisorderImmunologyCell DeathImmunologic Mechanism	2003	148
Mast Cells Augment Adaptive Immunity by Orchestrating Dendritic Cell Trafficking through Infected Tissues Christopher P. Shelburne, Hideki Nakano, Ashley L. St. John, Cell Host & Microbe InflammationAutoimmune DiseaseAdaptive Immune SystemMast Cell DisorderInnate Immune System	2009	138
Combined Stimulation with the T Helper Cell Type 2 Cytokines Interleukin (Il)-4 and IL-10 Induces Mouse Mast Cell Apoptosis C. Fitzhugh Yeatman, Sarah M. Jacobs-Helber, Paria Mirmonsef, The Journal of Experimental Medicine	2000	83
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen Afton L. McGowen, Laura P. Hale, Christopher P. Shelburne, Vaccine VaccinationMucosal VaccinationMast Cell DisorderImmunologyTherapeutic Vaccine	2009	82
IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mechanism. John J. Ryan, Shirley K. DeSimone, Gregory Klisch, PubMed Mast Cell DisorderImmune RegulationImmunologyImmunologic MechanismImmune System	1998	81
Burr Hole Washout versus Craniotomy for Chronic Subdural Hematoma: Patient Outcome and Cost Analysis Jacqueline M. Regan, Emmagene Worley, Christopher P. Shelburne, PLoS ONE	2015	76
IL-10 Inhibits FcεRI Expression in Mouse Mast Cells Sheila R. Gillespie, Randall R. DeMartino, Jingfang Zhu, The Journal of Immunology	2004	69
IL-4 Inhibits Mouse Mast Cell FcεRI Expression Through a STAT6-Dependent Mechanism John J. Ryan, Shirley K. DeSimone, Gregory Klisch, The Journal of Immunology InflammationStat6-dependent MechanismCytokineAllergyImmune Cell Development	1998	68

Page 1